Clinical Guest Contributors

  1. Imunon Talks Passionate PIs, Endpoint Selection In Frontline Ovarian Cancer Trials 7/9/2025

    IMUNON CEO Stacy Lindborg, Ph.D. details the company’s successes in site selection, as well as trial design and execution, in Phase 2 and 3 trials for IMNN-001, a frontline treatment for ovarian cancer.

  2. Dear Pharma, The Creator Economy Is NOT Only For Beauty 7/7/2025

    Empactful Ventures CEO Denise N. Bronner has a message for pharma when it comes to influencer marketing: Adapt or become invisible. Here, she details the hazards of overlooking this powerful media channel.

  3. 2 Challenges In Designing A Clinical Trial Exploring Personalized Elimination Diets 7/3/2025

    Vibrant Wellness clinical coordinator Suzanne Barker, MS, RDN, LDN, CGP, discusses how they faced and resolved two key issues when conducting a food sensitivity clinical trial.

  4. Accurate Diagnosis And Enrollment Criteria Improve Intracerebral Hemorrhage Research 7/2/2025

    CEO Marc Deschamps shares how ischemic stroke treatment has overshadowed that of intracerebral hemorrhage, negatively impacting recruitment for ICH clinical trials. To turn the tide, he advocates for accurate diagnoses, more specialized care, and less restrictive enrollment criteria.

  5. Hey, What's The Big Idea? Patient Enrollment Utterly Reimagined, That's What 7/1/2025

    What do air traffic control, nuclear power plants, and aircraft carriers have in common? Patient recruitment expert Tatty Scott argues clinical researchers should look at these industries to inspire more precise trial execution.

  6. Breaking Free From The Acronym Soup: Rethinking The Role Of Technology In Clinical Trials 6/30/2025

    Ascendis Pharma's Ivanna Rosendal details how clinical systems hinder clinical trial execution and why we should rethink how technology can support our trials.

  7. Gilead Art Campaign Captures The PBC Patient Experience, Inspires Patient-Centric Trials 6/27/2025

    Gilead’s Carrie Frenette discusses the company's art campaign centered on primary biliary cholangitis to bring awareness to the condition and create more patient-centric trials for patients.

  8. Population-Aware Medicine: Mitigating Racial Disparities In Efficacy And Accuracy 6/26/2025

    Medicine is not one-size-fits-all. Here, strategic advisor Bill Hanlon implores pharma to develop therapeutics and diagnostics anchored by racial and ethnic diversity.

  9. It's Time To Change How We Engage Research Sites 6/25/2025

    Site operations expert Maria Ladd argues for a major change in how sponsors and CROs communicate and work with clinical research sites.

  10. The Effects Of Most Favored Nation Drug Pricing On Clinical Trial Management 6/24/2025

    Market expert Mathini Ilancheran explains how sponsors can mitigate the effects of "Most Favored Nation" drug pricing while maintaining trial integrity and accelerating time to market.